The Medical Oncology Training program at New York University (NYU) is in its 25th year and several of its trainees have made outstanding contributions to clinical research. With the institutional commitment to a New York University Cancer Institute in September 2000, the Program Director and Training Faculty at NYU have further consolidated many ingredients of their program in order to provide a comprehensive training in Cancer Medicine. We propose to train four research-dedicated M.D.s per year among post-doctoral fellows seeking a career in an oncologic subspecialty after completing their Internal Medicine training. The following are emerging noteworthy aspects of this program: 1) a growing pool of talented applicants interested in our Medical Oncology/Hematology fellowship, 2) a policy to preferentially accept into the program individuals seeking research opportunities and to cultivate their interests from the outset; 3) an experienced and accomplished faculty with an enviable track record of mentoring trainees in basic, translational, as well as clinical research; and, 4) a steady exposure to activities including formal courses that foster the development of research skills, and ethical conduct. Moreover, the research environment recently created the NYU Cancer Institute and prominent recruitments into several clinical oncology specialties are new valuable assets of this program. The Program Director will dedicate a major portion of his time to this program, with the expectation that this new generation of trainees will become accomplished leaders in clinical oncology, and will be in positions to contribute in major ways to the evolving sciences of cancer therapeutics and other important aspects of cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009454-20
Application #
7069109
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
1984-09-01
Project End
2010-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
20
Fiscal Year
2006
Total Cost
$221,991
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Smith, Julia; Dilawari, Asma; Ursin, Giske et al. (2012) A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density. Anticancer Res 32:1327-31
Huynh, Chanh; Poliseno, Laura; Segura, Miguel F et al. (2011) The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma. PLoS One 6:e25264
Mirchandani, Deepu; Roses, Daniel F; Inghirami, Giorgio et al. (2011) Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma. Anticancer Res 31:4401-5
Huynh, C; Segura, M F; Gaziel-Sovran, A et al. (2011) Efficient in vivo microRNA targeting of liver metastasis. Oncogene 30:1481-8
Seetharamu, N; Kim, E; Hochster, H et al. (2010) Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer. Anticancer Res 30:541-5
Andreopoulou, Eleni; Gaiotti, Darci; Kim, Eugene et al. (2007) Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer. Clin Breast Cancer 7:690-6
Andreopoulou, E; Yee, H; Warycha, M A et al. (2007) Mucinous cancer of the appendix: challenges in diagnosis and treatment. J Chemother 19:451-4
Andreopoulou, E; Gaiotti, D; Kim, E et al. (2007) Pegylated liposomal doxorubicin HCL (PLD;Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer. Ann Oncol 18:716-21
Pulte, Dianne; Li, Eric; Crawford, Bernard K et al. (2005) Sentinel lymph node mapping and molecular staging in nonsmall cell lung carcinoma. Cancer 104:1453-61
Afonja, O; Smith Jr, J E; Cheng, D M et al. (2000) MEIS1 and HOXA7 genes in human acute myeloid leukemia. Leuk Res 24:849-55

Showing the most recent 10 out of 24 publications